health
"Voice of Patients, Medicine Tailored to Us": Immunotherapy in Focus of Modern Treatment
On the occasion of May, the month of fighting bladder cancer, the Association of Patients for Fighting Cancer of the Bladder, Prostate, Testes, and Kidneys "Uro takt", together with experts, is launching the campaign "Voice of Patients, Medicine Tailored to Us", it was announced today from the association, which highlights that immunotherapy is in the focus of modern treatment of bladder cancer.
TL;DR
- The "Voice of Patients, Medicine Tailored to Us" campaign aims to improve bladder cancer treatment in Serbia.
- Immunotherapy is highlighted as a key focus in modern bladder cancer treatment.
- Despite advances, many patients still face challenges in accessing modern therapies.
- Bladder cancer affects approximately 2,500 people annually in Serbia, with over 1,000 deaths.
- Risk factors include smoking, chemical exposure, chronic infections, and genetic predisposition.
- Early diagnosis, especially noting blood in urine, is crucial for better treatment outcomes.
- New therapeutic options, including immunotherapy, are becoming available for different stages of bladder cancer.
- The combination of chemotherapy and immunotherapy is recognized as a new standard for invasive bladder cancer.
- Immunotherapy in maintenance therapy for metastatic bladder cancer significantly prolongs survival.
- There is a push to include immunotherapy for metastatic bladder cancer on the positive list of the Serbian Health Insurance Fund (RFZO).